Thomas F. Tropea

656 total citations
20 papers, 312 citations indexed

About

Thomas F. Tropea is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Thomas F. Tropea has authored 20 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 8 papers in Physiology and 6 papers in Psychiatry and Mental health. Recurrent topics in Thomas F. Tropea's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (7 papers) and Dementia and Cognitive Impairment Research (5 papers). Thomas F. Tropea is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (7 papers) and Dementia and Cognitive Impairment Research (5 papers). Thomas F. Tropea collaborates with scholars based in United States, China and Sweden. Thomas F. Tropea's co-authors include Alice Chen‐Plotkin, David A. Wolk, Edward B. Lee, Katheryn A Q Cousins, David J. Irwin, Huanhuan Wang, Yuling Liang, Lu Yang, Dejian Ren and Kelvin C. Luk and has published in prestigious journals such as Nature, Neurology and Annals of Neurology.

In The Last Decade

Thomas F. Tropea

19 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas F. Tropea United States 10 125 114 65 55 40 20 312
M. Sévin France 4 59 0.5× 221 1.9× 72 1.1× 89 1.6× 23 0.6× 9 366
Theresa König Austria 9 131 1.0× 108 0.9× 131 2.0× 32 0.6× 37 0.9× 35 394
Louise Bier United States 9 161 1.3× 222 1.9× 90 1.4× 77 1.4× 38 0.9× 16 485
Pierre Labauge France 11 172 1.4× 103 0.9× 193 3.0× 69 1.3× 52 1.3× 31 499
Aidan Kenny Ireland 7 38 0.3× 98 0.9× 183 2.8× 41 0.7× 45 1.1× 10 369
Elżbieta Pasennik Poland 12 103 0.8× 90 0.8× 101 1.6× 36 0.7× 176 4.4× 21 397
Mar O’Callaghan Spain 12 52 0.4× 125 1.1× 273 4.2× 42 0.8× 27 0.7× 26 489
Jean C. Cruz Hernández United States 5 110 0.9× 137 1.2× 48 0.7× 47 0.9× 83 2.1× 7 274
Elisa Ferrer Spain 9 159 1.3× 60 0.5× 111 1.7× 11 0.2× 66 1.6× 20 430
Matthew D. Howe United States 11 72 0.6× 77 0.7× 57 0.9× 29 0.5× 68 1.7× 23 267

Countries citing papers authored by Thomas F. Tropea

Since Specialization
Citations

This map shows the geographic impact of Thomas F. Tropea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Tropea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Tropea more than expected).

Fields of papers citing papers by Thomas F. Tropea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Tropea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Tropea. The network helps show where Thomas F. Tropea may publish in the future.

Co-authorship network of co-authors of Thomas F. Tropea

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Tropea. A scholar is included among the top collaborators of Thomas F. Tropea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Tropea. Thomas F. Tropea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Christopher, Sandhitsu R. Das, Katheryn A Q Cousins, et al.. (2025). Tau burden is best captured by magnitude and extent: Tau‐MaX as a measure of global tau. Alzheimer s & Dementia. 21(7). e70346–e70346. 2 indexed citations
2.
Cousins, Katheryn A Q, Jeffrey S. Phillips, Sandhitsu R. Das, et al.. (2024). Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease. Alzheimer s & Dementia. 20(6). 3889–3905. 16 indexed citations
3.
Kannarkat, George T., James F. Morley, Kelvin C. Luk, et al.. (2024). Alpha-Synuclein Strains in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies (S26.006). Neurology. 102(7_supplement_1). 1 indexed citations
4.
Cousins, Katheryn A Q, David J. Irwin, Alice Chen‐Plotkin, et al.. (2023). Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease. Annals of Clinical and Translational Neurology. 10(5). 802–813. 20 indexed citations
5.
Zuroff, Leah, Laura E.M. Wisse, Sharon X. Xie, et al.. (2022). Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline. Journal of Alzheimer s Disease Reports. 6(1). 411–430. 9 indexed citations
6.
Cousins, Katheryn A Q, Leslie M. Shaw, Sanjana Shellikeri, et al.. (2022). Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis. Annals of Neurology. 92(5). 807–818. 28 indexed citations
7.
Zuroff, Leah, Ayman Rezk, Koji Shinoda, et al.. (2022). Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age. EBioMedicine. 82. 104179–104179. 29 indexed citations
8.
Cousins, Katheryn A Q, Andrew Siderowf, John E. Duda, et al.. (2022). Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers. Parkinsonism & Related Disorders. 100. 33–36. 7 indexed citations
9.
Tropea, Thomas F., Teresa Waligórska, Sharon X. Xie, et al.. (2022). Plasma Phosphorylated Tau181 is a Biomarker of Alzheimer's Disease Pathology and Associated with Cognitive and Functional Decline. SSRN Electronic Journal. 4 indexed citations
10.
Wie, Jinhong, Zhenjiang Liu, Thomas F. Tropea, et al.. (2021). A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology. Nature. 591(7850). 431–437. 86 indexed citations
11.
Guo, Michael H., Tanya Bardakjian, Steven S. Scherer, et al.. (2021). Temporal trends and yield of clinical diagnostic genetic testing in adult neurology. American Journal of Medical Genetics Part A. 185(10). 2922–2928. 13 indexed citations
12.
Wie, Jinhong, Zhenjiang Liu, Thomas F. Tropea, et al.. (2021). Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology. Nature. 592(7855). E10–E10. 3 indexed citations
13.
Uemura, Maiko, John Robinson, Katheryn A Q Cousins, et al.. (2021). Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Acta Neuropathologica. 143(1). 15–31. 35 indexed citations
14.
Baldwin, Aaron F., et al.. (2021). Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurology. Journal of Genetic Counseling. 30(4). 974–983. 19 indexed citations
15.
Tropea, Thomas F., Jacqueline Rick, EunRan Suh, et al.. (2021). Whole Clinic Research Enrollment in Parkinson’s Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. Journal of Parkinson s Disease. 11(2). 757–765. 6 indexed citations
16.
Spindler, Meredith, Dina Jacobs, Thomas F. Tropea, et al.. (2020). A Department Approach to Teleneurology. Telemedicine Journal and e-Health. 27(9). 1078–1084. 9 indexed citations
17.
Stein, Laura, et al.. (2020). Perceptions of Functional Neurological Disorders Among Medical Students (2132). Neurology. 94(15_supplement).
18.
Cousins, Katheryn A Q, Katya Rascovsky, Naomi Nevler, et al.. (2020). Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology (4234). Neurology. 94(15_supplement). 1 indexed citations
19.
Dai, David, Thomas F. Tropea, John Robinson, et al.. (2020). ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s disease and Dementia with Lewy bodies. Acta Neuropathologica. 140(4). 449–461. 9 indexed citations
20.
Tropea, Thomas F. & Alice Chen‐Plotkin. (2017). Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease. Parkinsonism & Related Disorders. 46. S15–S18. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Sévin Breakdown of academic impact, for papers by Theresa König Breakdown of academic impact, for papers by Louise Bier Breakdown of academic impact, for papers by Pierre Labauge Breakdown of academic impact, for papers by Aidan Kenny Breakdown of academic impact, for papers by Elżbieta Pasennik Breakdown of academic impact, for papers by Mar O’Callaghan Breakdown of academic impact, for papers by Jean C. Cruz Hernández Breakdown of academic impact, for papers by Elisa Ferrer Breakdown of academic impact, for papers by Matthew D. Howe
Rankless by CCL
2026